|
|
||||||||
Department of Physiology, University of Tennessee, Memphis, Tennessee 38163
Submitted 24 January 2003 ; accepted in final form 21 May 2003
Activation of myocardial
-opioid receptor-protein kinase C (PKC)
pathways may improve postischemic contractile function through a myofilament
reduction in ATP utilization. To test this, we first examined the effects of
PKC inhibitors on
-opioid receptor-dependent cardioprotection. The
-opioid receptor agonist U50,488H (U50) increased postischemic left
ventricular developed pressure and reduced postischemic end-diastolic pressure
compared with controls. PKC inhibitors abolished the cardioprotective effects
of U50. To determine whether
-opioid-PKC-dependent decreases in
Ca2+-dependent actomyosin
Mg2+-ATPase could account for cardioprotection, we
subjected hearts to three separate actomyosin ATPase-lowering protocols. We
observed that moderate decreases in myofibrillar ATPase were equally
cardioprotective as
-opioid receptor stimulation. Immunoblot analysis
and confocal microscopy revealed a
-opioid-induced increase in
myofilament-associated PKC-
, and myofibrillar
Ca2+-independent PKC activity was increased after
-opioid stimulation. This PKC-myofilament association led to an
increase in troponin I and C-protein phosphorylation. Thus we propose
PKC-
activation and translocation to the myofilaments causes a decrease
in actomyosin ATPase, which contributes to the
-opioid
receptor-dependent cardioprotective mechanism.
U50,488H; Western blot; confocal microscopy; protein kinase C activity; left ventricular developed pressure;
-opioid
This article has been cited by other articles:
![]() |
B. C. Blunt, Y. Chen, J. D. Potter, and P. A. Hofmann Modest actomyosin energy conservation increases myocardial postischemic function Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1088 - H1096. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |